指南与共识消化道肿瘤与早癌消化内镜

英国胃肠病学会关于结直肠锯齿状息肉的立场声明

British Society of Gastroenterology position statement on serrated polyps in the colon and rectum.
指南 / 共识 · Gut · 2017-04-27

英国胃肠病学会(BSG)内镜组委托工作组制定立场声明,基于有限证据并经Delphi流程达成>80%共识,采用GRADE工具评估证据与推荐强度。关键推荐:对具有较高未来肿瘤或结直肠癌风险的SSLs(≥10 mm或含异型增生的锯齿状病变,包括传统锯齿状腺瘤),建议在3年时提供一次性结肠镜监测(弱推荐,低质量证据,90%共识)。

要点

  • 对SSLs≥10 mm或含异型增生的锯齿状病变(含传统锯齿状腺瘤),建议3年时一次性结肠镜监测(弱推荐,低质量证据)。
  • 该建议基于有限证据,待监测疗效证据发表后再评估。
  • 立场声明涵盖锯齿状病变的癌前潜能、检出与切除、监测策略、锯齿状息肉病综合征及结肠炎中的锯齿状病变等。

核心结论

  • 在进一步监测疗效证据发表前,对具有较高未来肿瘤或结直肠癌风险的SSLs(≥10 mm或含异型增生的锯齿状病变,包括传统锯齿状腺瘤),建议在3年时提供一次性结肠镜监测(弱推荐,低质量证据,90%共识)。

研究设计与样本

  • 英国胃肠病学会(BSG)内镜组委托工作组制定立场声明,经Delphi流程修改直至>80%共识,采用GRADE工具评估证据强度与推荐强度。

主要发现

  • 锯齿状息肉在过去十年被认识为重要癌前病变,占结直肠癌的15%至30%。
  • 立场声明范围包括:锯齿状病变癌前潜能的证据;锯齿状病变的检出与切除;检出后的监测策略;特殊情况——锯齿状息肉病综合征(包括手术)及结肠炎中的锯齿状病变;教育、审计与基准及研究问题。

关键数值与推荐

  • 对SSLs≥10 mm或含异型增生的锯齿状病变(包括传统锯齿状腺瘤),建议在3年时提供一次性结肠镜监测(弱推荐,低质量证据,90%共识)。

临床怎么用

  • 对SSLs≥10 mm或含异型增生的锯齿状病变(包括传统锯齿状腺瘤)的患者,建议在3年时提供一次性结肠镜监测(弱推荐,低质量证据)。

局限性

  • 证据基础有限。
  • 在进一步监测疗效证据发表前,该建议为弱推荐、低质量证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Serrated polyps have been recognised in the last decade as important premalignant lesions accounting for between 15% and 30% of colorectal cancers. There is therefore a clinical need for guidance on how to manage these lesions; however, the evidence base is limited. A working group was commission by the British Society of Gastroenterology (BSG) Endoscopy section to review the available evidence and develop a position statement to provide clinical guidance until the evidence becomes available to support a formal guideline. The scope of the position statement was wide-ranging and included: evidence that serrated lesions have premalignant potential; detection and resection of serrated lesions; surveillance strategies after detection of serrated lesions; special situations-serrated polyposis syndrome (including surgery) and serrated lesions in colitis; education, audit and benchmarks and research questions. Statements on these issues were proposed where the evidence was deemed sufficient, and re-evaluated modified via a Delphi process until >80% agreement was reached. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) tool was used to assess the strength of evidence and strength of recommendation for finalised statements. Key recommendation: we suggest that until further evidence on the efficacy or otherwise of surveillance are published, patients with sessile serrated lesions (SSLs) that appear associated with a higher risk of future neoplasia or colorectal cancer (SSLs ≥10 mm or serrated lesions harbouring dysplasia including traditional serrated adenomas) should be offered a one-off colonoscopic surveillance examination at 3 years (weak recommendation, low quality evidence, 90% agreement).

来源:Gut,查看原文。版权归原作者所有。

引用

  1. East JE, Atkin WS, Bateman AC, et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017. PMID: 28450390. doi:10.1136/gutjnl-2017-314005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。